MedTrace Logo

Assessing Quality of Life of Patients With Prostate Cancer

NCT00041301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 625

Last updated 2012-08-27

No results posted yet for this study

Summary

RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate and long-term effects of the treatment on these patients.

PURPOSE: Clinical trial to study the effectiveness of two questionnaires in assessing quality of life of patients who have prostate cancer.

Conditions

Interventions

OTHER

QoL assessment

qol questionnaires

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Neil K. Aaronson, PhD · The Netherlands Cancer Institute

  • George Van Andel, MD · Onze Lieve Vrouwe Gasthuis

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Primary Completion
2004-12-31
Completion
2005-11-30

Countries

  • Australia
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Romania
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00041301 on ClinicalTrials.gov